Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
.
. .
.
Chrome 2001
Chrome 2001
Health News Health News
.
Hormone Might Help Preemies' Brains
August 26, 2014

 

TUESDAY, Aug. 26, 2014 (HealthDay News) -- A hormone used to reduce the need for blood transfusions might also protect the brains of premature babies, a new study suggests.

Synthetic erythropoietin (EPO), which stimulates red blood cell production, appears to prevent brain damage when used shortly after preterm birth, said lead researcher Dr. Petra Huppi, a professor of pediatrics and newborn medicine at the University of Geneva, in Switzerland.

"The real test of whether EPO protects the brains of these children will be when they are evaluated when they are older," she said.

Infants born before the 32nd week of pregnancy face dire health risks, including brain damage and incomplete development of the brain, especially the part of the brain called white matter.

Many are left with long-term developmental disabilities, including motor and thinking problems, and attention and learning difficulties, the researchers noted.

Huppi noted that EPO, commonly used to treat anemia, is safe and has no side effects. It's been used to treat premature infants for decades, she said. Its use as a performance enhancer in sports has been banned.

In the first step of the study, published in the Aug. 27 issue of the Journal of the American Medical Association, researchers reviewed MRI brain scans of 165 infants. Close to half had received three doses of EPO within two days of delivery.

MRI scans done when the infants were the equivalent age of a full-term birth found that the brains of babies who received EPO showed less damage than the brains of infants who hadn't been given the hormone.

According to Huppi, this is the first study that has shown a benefit of EPO on the brains of preterm babies.

However, Dr. David Mendez, a neonatologist at Miami Children's Hospital, remains skeptical.

"The role EPO has in protecting brain tissue is still theoretical and not proven," he said. "This study raises more questions than it answers."

Over the years, many different drugs have been tried to preserve the brain tissue of preemies, Mendez said. "The most recent incarnation of this is the use of EPO," he said. But still more work is needed, Mendez said.

In this study, too few children were given EPO to say the findings weren't purely by chance, he said. The association reported in the study does not prove a cause-and-effect relationship.

Mendez also said that although EPO has been used for years to reduce the need for blood transfusions in preemies, its use is falling out of favor.

"There has been some concern that EPO reduces white blood cell counts and there is some concern that EPO may predispose the baby to have an eye condition called 'retinopathy of prematurity' that can lead to blindness," he said. "A lot of neonatologists don't even use EPO anymore."

As for the brain scans, Mendez said it's easy to tell a completely normal brain from a completely damaged one, but it's not as easy to evaluate the area between the two, which is where most preemies fall, he said.

Huppi said the next stage of the study is to test the children when they are 2 and 5 years old. This assessment will confirm whether or not EPO really protects the brains of premature babies, she said.

"If this does turn out to be the case, this will be an important step in preventing brain damage and its consequences in premature babies," Huppi said.

More information

For more about premature babies, visit the March of Dimes.
Copyright © 2014 HealthDay. All rights reserved.


SOURCES: Petra Huppi, M.D., professor, pediatrics and newborn medicine, University of Geneva, Switzerland; David Mendez, M.D., neonatologist, Miami Children's Hospital; Aug. 27, 2014, Journal of the American Medical Association...

InteliHealth
.
.
.
.
.
More News
InteliHealth .
.
General Health News
Today's News
Today In Health History
This Week In Health
Addiction News
Allergy News
Alzheimer's News
Arthritis News
Asthma News
Babies News
Breast Cancer News
Bronchitis News
Cancer News
Cervical Cancer News
Children's Health News
Cholesterol News
Dental/Oral Health News
Depression News
Diabetes News
Ear, Nose And Throat News
Environmental Health News
Eye News
Fitness News
Genetics News
Headache News
Health Policy News
Heart Attack News
Heart Failure News
Heart Health News
HIV/AIDS News
Infectious Diseases News
Influenza News
Lung Cancer News
Medication News
Men's Health News
Mental Health News
Multiple Sclerosis News
Nutrition News
Parkinson's News
Pregnancy News
Prostate Cancer News
Schizophrenia
Senior Health News
Sexual/Reproductive Health News
Sexual dysfunction
Sleep News
STDs News
Stroke News
Tobacco Cessation News
Weight Management News
Women's Health News
.
.
.
.
InteliHealth
    Print Printer-friendly format    
   
.  
This website is certified by Health On the Net Foundation. Click to verify.
.